A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Naltrexone (Primary) ; Naltrexone (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 02 May 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.
- 02 May 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.
- 06 Dec 2016 New trial record